These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9070014)

  • 1. Parenteral iron supplementation.
    Kumpf VJ
    Nutr Clin Pract; 1996 Aug; 11(4):139-46. PubMed ID: 9070014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenteral iron dextran therapy: a review.
    Burns DL; Mascioli EA; Bistrian BR
    Nutrition; 1995; 11(2):163-8. PubMed ID: 7647482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral iron dextran therapy.
    Kumpf VJ; Holland EG
    DICP; 1990 Feb; 24(2):162-6. PubMed ID: 2106757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy.
    Ayub R; Tariq N; Adil MM; Iqbal M; Junaid A; Jaferry T
    J Coll Physicians Surg Pak; 2008 Jul; 18(7):424-7. PubMed ID: 18760066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral iron supplementation for the treatment of iron deficiency anemia in children.
    Surico G; Muggeo P; Muggeo V; Lucarelli A; Martucci T; Daniele M; Rigillo N
    Ann Hematol; 2002 Mar; 81(3):154-7. PubMed ID: 11904741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of intravenous iron dextran injection in children receiving total parenteral nutrition.
    Reed MD; Bertino JS; Halpin TC
    Am J Dis Child; 1981 Sep; 135(9):829-31. PubMed ID: 6792906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel short-course regimen of intramuscular iron therapy for anaemic pregnant women.
    Thirunavukkarasu S; Bhandary A
    Trop Doct; 2009 Oct; 39(4):227-8. PubMed ID: 19671779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral iron therapy in the treatment of iron deficiency anemia during pregnancy: a randomized controlled trial.
    Tariq N; Ayub R; Khan WU; Ijaz S; Alam AY
    J Coll Physicians Surg Pak; 2015 Mar; 25(3):193-7. PubMed ID: 25772960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parenteral iron therapy: problems and possible solutions].
    Hoigné R; Breymann C; Künzi UP; Brunner F
    Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease.
    Koutroubakis IE; Oustamanolakis P; Karakoidas C; Mantzaris GJ; Kouroumalis EA
    Dig Dis Sci; 2010 Aug; 55(8):2327-31. PubMed ID: 19834803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral iron therapy options.
    Silverstein SB; Rodgers GM
    Am J Hematol; 2004 May; 76(1):74-8. PubMed ID: 15114602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral versus high dose parenteral iron supplementation in pregnancy.
    Kumar A; Jain S; Singh NP; Singh T
    Int J Gynaecol Obstet; 2005 Apr; 89(1):7-13. PubMed ID: 15777891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
    Plummer ES; Crary SE; McCavit TL; Buchanan GR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron supplementation moderates but does not cure the Belgrade anemia.
    Garrick M; Scott D; Walpole S; Finkelstein E; Whitbred J; Chopra S; Trivikram L; Mayes D; Rhodes D; Cabbagestalk K; Oklu R; Sadiq A; Mascia B; Hoke J; Garrick L
    Biometals; 1997 Apr; 10(2):65-76. PubMed ID: 9210290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron deficiency anemia: evaluation and management.
    Short MW; Domagalski JE
    Am Fam Physician; 2013 Jan; 87(2):98-104. PubMed ID: 23317073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintaining iron balance with total-dose infusion of intravenous iron dextran.
    Case G
    ANNA J; 1998 Feb; 25(1):65-8. PubMed ID: 9543911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Review by expert group in the diagnosis and treatment of anemia in pregnant women. Federación Mexicana de Colegios de Obstetricia y Ginecología].
    Montoya Romero Jde J; Castelazo Morales E; Valerio Castro E; Velázquez Cornejo G; Nava Muñoz DA; Escárcega Preciado JA; Montoya Cossío J; Pichardo Villalón GM; Maldonado Aragón A; Santana García HR; Fajardo Dueñas S; Mondragón Galindo CG; García Lee T; García A; Hernández de Morán M; Chávez Güitrón LE; Jiménez Gutiérrez C;
    Ginecol Obstet Mex; 2012 Sep; 80(9):563-80. PubMed ID: 23243836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic and erythropoietin responses to iron dextran in the hemodialysis environment.
    Senger JM; Weiss RJ
    ANNA J; 1996 Jun; 23(3):319-23; discussion 324-5. PubMed ID: 8716991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative rates of adverse events with different formulations of intravenous iron.
    Okam MM; Mandell E; Hevelone N; Wentz R; Ross A; Abel GA
    Am J Hematol; 2012 Nov; 87(11):E123-4. PubMed ID: 22965928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical practice guidelines for maintaining adequate iron status with intravenous iron dextran in hemodialysis patients.
    Peacock E; Lindenfeld SM
    ANNA J; 1999 Jun; 26(3):337-43. PubMed ID: 10633605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.